Published in J Nucl Cardiol on September 10, 2007
Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging (2009) 1.04
Cardiac amyloidosis detected on tc-99m bone scan. Nucl Med Mol Imaging (2014) 0.75
Nuclear imaging of amyloidosis. Pol J Radiol (2014) 0.75
Universal definition of myocardial infarction. Circulation (2007) 11.69
The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol (2006) 5.58
Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med (2009) 5.34
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet (2009) 5.23
Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med (2008) 4.91
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89
Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J (2001) 3.49
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation (2009) 2.34
Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation (2007) 2.22
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol (2009) 2.20
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. J Am Coll Cardiol (2012) 2.11
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet (2003) 2.10
A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. Am Heart J (2007) 2.01
Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation (2006) 2.00
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol (2005) 1.99
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2007) 1.92
Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study. Int J Cardiol (2008) 1.87
Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation (2005) 1.85
Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation (2008) 1.84
Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol (2011) 1.79
The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. J Am Coll Cardiol (2004) 1.75
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin Cancer Res (2012) 1.67
Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res (2007) 1.61
Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy. Eur Heart J (2006) 1.58
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET. J Am Coll Cardiol (2007) 1.58
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol (2008) 1.57
A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET). J Am Coll Cardiol (2006) 1.57
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial. J Hypertens (2005) 1.56
Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom. Eur J Heart Fail (2005) 1.54
Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes. Am J Physiol Heart Circ Physiol (2012) 1.53
Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study. Eur J Echocardiogr (2007) 1.47
The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol (2005) 1.43
Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease. Br Heart J (1989) 1.42
SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure. Circ Arrhythm Electrophysiol (2011) 1.40
Symptoms in patients with heart failure are prognostic predictors: insights from COMET. J Card Fail (2005) 1.40
Dimensional accuracy of magnetic resonance in studies of the heart. Lancet (1985) 1.37
Multimodality cardiac imaging in the evaluation of mitral annular caseous calcification. Circulation (2011) 1.36
The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cardiol (2000) 1.34
Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol (1995) 1.32
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J (2008) 1.27
In vivo validation of MR velocity imaging. J Comput Assist Tomogr (1987) 1.25
The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J (2006) 1.20
Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol (1992) 1.18
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J (2004) 1.13
Blood flow patterns in the human aorta studied by magnetic resonance. Br Heart J (1987) 1.13
Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol (2003) 1.12
Procedure guidelines for radionuclide myocardial perfusion imaging. Heart (2004) 1.11
Magnetic resonance velocity mapping: clinical application of a new technique. Br Heart J (1987) 1.09
Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Circulation (1993) 1.07
Pulmonary artery distensibility and blood flow patterns: a magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension. Am Heart J (1989) 1.06
Assessment of regional left ventricular function by magnetic resonance. Br Heart J (1986) 1.06
Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. Eur J Heart Fail (2009) 1.04
Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links. Cardiovasc Res (2006) 1.04
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials. Eur J Heart Fail (2009) 1.03
Bradycardia progressing to cardiac arrest during adenosine thallium myocardial perfusion imaging in occult sino-atrial disease. Eur J Nucl Med (1994) 1.02
Magnetic resonance imaging of the pulmonary arteries and their systemic connections in pulmonary atresia: comparison with angiographic and surgical findings. Br Heart J (1987) 1.02
Computation of flow pressure fields from magnetic resonance velocity mapping. Magn Reson Med (1996) 1.01
Heart rate response during exercise predicts survival in adults with congenital heart disease. J Am Coll Cardiol (2006) 1.00
Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol (1991) 1.00
Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation (2006) 1.00
Lymphoepithelioma-like carcinoma of the skin: a case with lymph node metastases at presentation. Am J Dermatopathol (2006) 0.99
Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major. Lancet (1984) 0.98
Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation (1998) 0.97
Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA (2009) 0.95
Diuretics for heart failure. Cochrane Database Syst Rev (2012) 0.95
The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification: a study in type 1 diabetic patients and the general population. Diabetes Care (2001) 0.94
Evidence-based review: quality of life following head and neck intensity-modulated radiotherapy. Radiother Oncol (2010) 0.93
Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants. Eur J Heart Fail (2009) 0.93
Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma. Am J Cardiol (1993) 0.92
Viable myocardium and reinjection of thallium. Br Heart J (1992) 0.91
Familial nonmedullary thyroid cancer: a review of the genetics. Thyroid (2010) 0.91
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. Int J Cardiol (2006) 0.90
Valve and great vessel stenosis: assessment with MR jet velocity mapping. Radiology (1991) 0.90
The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck. Expert Opin Ther Targets (2005) 0.90
Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes (2001) 0.90
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. J Card Fail (2004) 0.90
Quorum sensing and density-dependent dispersal in an aquatic model system. PLoS One (2012) 0.89
Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization. J Med Screen (2011) 0.88
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure. Int J Cardiol (2007) 0.88
Cardiothoracic ratio from postero-anterior chest radiographs: a simple, reproducible and independent marker of disease severity and outcome in adults with congenital heart disease. Int J Cardiol (2011) 0.88
Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model. Pharmacoeconomics (2008) 0.88
Left ventricular long axis disturbances as predictors for thallium perfusion defects in patients with known peripheral vascular disease. Heart (1998) 0.87
Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors. Am J Cardiol (2005) 0.87
Follicular thyroid carcinoma metastasis to the esophagus detected by 18FDG PET/CT. Thyroid (2008) 0.87
Regenerative capacity of the myocardium: implications for treatment of heart failure. Lancet (2004) 0.87
Magnetic resonance imaging of coronary arteries: technique and preliminary results. Br Heart J (1993) 0.87
Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II). Am Heart J (2005) 0.87
Magnetic resonance imaging: a method for the assessment of changes in vascular structure and function. J Hum Hypertens (1991) 0.87
Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000. BMC Cancer (2014) 0.87
An automated algorithm for determining conduction velocity, wavefront direction and origin of focal cardiac arrhythmias using a multipolar catheter. Conf Proc IEEE Eng Med Biol Soc (2014) 0.87
Assessment of coronary artery stenosis by magnetic resonance imaging. Heart (1996) 0.87
Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol (2009) 0.87
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail (2007) 0.86
Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J Card Fail (2009) 0.86
Procedure guidelines for radionuclide myocardial perfusion imaging. Nucl Med Commun (2003) 0.86